Lucie Laurent
Clichy-sous-bois, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Risk prediction model for high-grade dysplasia in resected pancreatic mucinous cystic neoplasms: a nomogram-based approach.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: September 07, 2025
Comparison of radiological and pathological tools to assess response to neoadjuvant treatment in resected pancreatic ductal adenocarcinoma patients.
Journal: Therapeutic advances in medical oncology
Published: August 02, 2025
The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: November 17, 2022
Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens.
Journal: Therapeutic advances in medical oncology
Published: November 03, 2022
Microangiopathy associated with gemcitabine: a drug interaction with nab-paclitaxel? A case series and literature review.
Journal: European journal of clinical pharmacology
Published: March 09, 2022
MRI is useful to suggest and exclude malignancy in mucinous cystic neoplasms of the pancreas.
Journal: European radiology
Published: April 06, 2021
CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: March 11, 2018
Estimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantation.
Journal: United European gastroenterology journal
Published: June 21, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026